{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:52:24Z","timestamp":1790661144555,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T00:00:00Z","timestamp":1660953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["09150182010007"],"award-info":[{"award-number":["09150182010007"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["91713319"],"award-info":[{"award-number":["91713319"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["337479"],"award-info":[{"award-number":["337479"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jhepr.2022.100573","type":"journal-article","created":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T20:07:50Z","timestamp":1661630870000},"page":"100573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Systemic ASBT inactivation protects against liver damage in obstructive cholestasis in mice"],"prefix":"10.1016","volume":"4","author":[{"given":"Roni F.","family":"Kunst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk R.","family":"de Waart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Wolters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Duijst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5298-2910","authenticated-orcid":false,"given":"Esther W.","family":"Vogels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Bolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Verheij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5114-7799","authenticated-orcid":false,"given":"Ulrich","family":"Beuers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1779-0833","authenticated-orcid":false,"given":"Ronald P.J.","family":"Oude Elferink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4238-4359","authenticated-orcid":false,"given":"Stan F.J.","family":"van de Graaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2022.100573_bib1","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jhep.2015.10.024","article-title":"Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis","volume":"64","author":"Baghdasaryan","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2022.100573_bib2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/apt.13457","article-title":"The ileal bile acid transporter inhibitor A4250 decreases serum bile acids by interrupting the enterohepatic circulation","volume":"43","author":"Graffner","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2022.100573_bib3","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0140-6736(17)30319-7","article-title":"Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study","volume":"389","author":"Hegade","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2022.100573_bib4","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/hep4.1305","article-title":"A\u00a0randomized, controlled, phase 2 study of maralixibat in the treatment of itching associated with primary biliary cholangitis","volume":"3","author":"Mayo","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2022.100573_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12876-016-0481-9","article-title":"BAT117213: ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trial","volume":"16","author":"Hegade","year":"2016","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhepr.2022.100573_bib6","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3389\/fphar.2018.00931","article-title":"Ileal bile acid transporter inhibition for the treatment of chronic constipation, cholestatic pruritus, and NASH","volume":"9","author":"Al-Dury","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jhepr.2022.100573_bib7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jhep.2020.03.024","article-title":"Volixibat in adults with non-alcoholic steatohepatitis: 24-week interim\u00a0analysis from a randomized, phase II study","volume":"73","author":"Newsome","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2022.100573_bib8","doi-asserted-by":"crossref","first-page":"33920","DOI":"10.1074\/jbc.M306370200","article-title":"Targeted deletion of the ileal bile acid transporter eliminates enterohepatic cycling of bile acids in mice","volume":"278","author":"Dawson","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhepr.2022.100573_bib9","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1021\/jm400459m","article-title":"Discovery of a highly potent, nonabsorbable apical sodium-dependent bile acid transporter inhibitor (GSK2330672) for treatment of type 2 diabetes","volume":"56","author":"Wu","year":"2013","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.jhepr.2022.100573_bib10","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/hep.26012","article-title":"Monitoring bile acid transport in single living cells using a genetically encoded F\u00f6rster resonance energy transfer sensor","volume":"57","author":"van der Velden","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2022.100573_bib11","article-title":"Real time monitoring of intracellular bile acid dynamics using a genetically encoded FRET-based bile acid sensor","author":"Van de Wiel","year":"2016","journal-title":"J\u00a0Vis Exp"},{"key":"10.1016\/j.jhepr.2022.100573_bib12","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1042\/BJ20111234","article-title":"Homo- and hetero-dimeric architecture of the human liver Na\u207a-dependent taurocholate co-transporting protein","volume":"441","author":"Bijsmans","year":"2012","journal-title":"Biochem J"},{"key":"10.1016\/j.jhepr.2022.100573_bib13","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ijc.2910520217","article-title":"Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells","volume":"52","author":"Shimizu","year":"1992","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jhepr.2022.100573_bib14","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0304-3940(02)01423-4","article-title":"Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data","volume":"339","author":"Ramakers","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jhepr.2022.100573_bib15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/hep.27694","article-title":"Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na+-taurocholate cotransporting polypeptide knockout mice","volume":"62","author":"Slijepcevic","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2022.100573_bib16","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.047746","article-title":"Metabolomics and lipidomics in Caenorhabditis elegans using a single-sample preparation","volume":"14","author":"Molenaars","year":"2021","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.jhepr.2022.100573_bib17","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jhep.2014.02.012","article-title":"Nod2 deficiency protects mice from cholestatic liver disease by increasing renal excretion of bile acids","volume":"60","author":"Wang","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2022.100573_bib18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/hep.23265","article-title":"Mouse organic solute transporter alpha deficiency enhances renal excretion of bile acids and attenuates cholestasis","volume":"51","author":"Soroka","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2022.100573_bib19","doi-asserted-by":"crossref","first-page":"p49","DOI":"10.1159\/000074330","article-title":"Regulation of renal tubular bile acid transport in the early phase of an obstructive cholestasis in the rat","volume":"95","author":"Schlattjan","year":"2003","journal-title":"Nephron Physiol"},{"key":"10.1016\/j.jhepr.2022.100573_bib20","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1053\/gast.2001.29608","article-title":"Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the rat","volume":"121","author":"Lee","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2022.100573_bib21","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/hep.28257","article-title":"Engineered fibroblast growth factor 19 reduces liver injury and resolves sclerosing cholangitis in Mdr2-deficient mice","volume":"63","author":"Zhou","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2022.100573_bib22","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S2468-1253(18)30173-0","article-title":"The case for combining treatments for primary sclerosing cholangitis","volume":"3","author":"Roscam Abbing","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2022.100573_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154797","article-title":"A\u00a0new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage","volume":"120","author":"Huang","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.jhepr.2022.100573_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/hep4.1998","article-title":"Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury\u00a0in the Mdr2(-\/-) mouse model of sclerosing cholangitis via immunomodulatory effects","author":"Fuchs","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2022.100573_bib25","doi-asserted-by":"crossref","first-page":"158925","DOI":"10.1016\/j.bbalip.2021.158925","article-title":"The protective role of hydrophilic tetrahydroxylated bile acids (THBA)","volume":"1866","author":"Sheps","year":"2021","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555922001458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555922001458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:28:23Z","timestamp":1762900103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555922001458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S2589555922001458"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2022.100573","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic ASBT inactivation protects against liver damage in obstructive cholestasis in mice","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2022.100573","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100573"}}